Compound Name
(alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
|---|
| Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
|---|
BDBM10323
 | 9 | 9 | 0 | 6 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-2
- Caspase-3
- Caspase-4
- Caspase-6
- Caspase-7
- Caspase-8
- Caspase-9
| - (S)-1-Benzyl-5-{1-[2-(phenoxymethyl)pyrrolidinyl]sulfonyl}isatin
- 1-benzyl-5-{[(2S)-2-(phenoxymethyl)pyrrolidine-1-]sulfonyl}-2,3-dihydro-1H-indole-2,3-dione
- CHEMBL439753
- IST-3
- Isatin Sulfonamide 34
- JMC522188 Compound 2
- Pyrrolidine Isatin Analogue 2
|
BDBM12
 | 0 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | - BirA Bifunctional Protein
- BirA Bifunctional Protein Mutant (V214A)
- BirA Bifunctional Protein Mutant (V219A)
- BirA Bifunctional Protein Mutant (W223A)
- Streptavadin(N23A)
- Streptavadin(N23E)
- Streptavadin(S27A)
- Streptavadin(W108F)
- Streptavadin(W120F)
- Streptavadin(W79F)
- Streptavadin(Y43A)
- Streptavidin
- Streptavidin (Y43F)
- Tyrosine-protein kinase ABL1
| - 5-[(3aS,4S,6aR)-2-oxo-hexahydro-1H-thieno[3,4-d]imidazolidin-4-yl]pentanoic acid
- Biotin
- cid_171548
- cid_253
|
BDBM12341
 | 3 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2A6
- Cytochrome P450 2B6
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 2E1
- Cytochrome P450 3A
| - CHEMBL178681
- CHEMBL359657
- US8609708, 1
- US8609708, 31
- [5-(pyridin-3-yl)thiophen-2-yl]methanamine
- nicotine 3-heteroaromatic analogue 1a
|
BDBM12751
 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor IX
- Coagulation factor X
- Prothrombin
- Trypsin
- Trypsin II
- Trypsin-1
| - 1-(3-carbamimidoylphenyl)-3-methyl-N-[4-(2-sulfamoylphenyl)phenyl]-1H-pyrazole-5-carboxamide
- CHEMBL152854
- CHEMBL37251
- SN-429
|
BDBM14362
 | 5 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | - Homo sapiens phosphodiesterase 2A (PDE2A)
- Phosphodiesterase 1
- Phosphodiesterase 3
- cAMP-specific 3',5'-cyclic phosphodiesterase 4A
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- cGMP-specific 3',5'-cyclic phosphodiesterase
| - 6-(4-imidazol-1-ylphenyl)-5-methyl-4,5-dihydro-2H-pyridazin-3-one
- 6-[4-(1H-imidazol-1-yl)phenyl]-5-methyl-2,3,4,5-tetrahydropyridazin-3-one
- CI 930
- CI-930
|
BDBM143743
 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 1 (OX1)
- Orexin receptor type 2
- Orexin receptor type 2 (OX2)
| - US10183953, Example 2
- US8969352, 2
- US9611277, Example 125
- US9845333, 2
|
BDBM143751
 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 1 (OX1)
- Orexin receptor type 2
- Orexin receptor type 2 (OX2)
| - US10183953, Example 12
- US8969352, 12
- US9611277, Example 12
- US9845333, 12
|
BDBM14712
 | 5 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | - Dihydroorotate Dehydrogenase (DHODH)
- Dihydroorotate dehydrogenase
- Dihydroorotate dehydrogenase (quinone), mitochondrial
| - (2Z)-2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]but-2-enamide
- A77 1726
- CHEMBL973
- CHEMBL999
- TERIFLUNOMIDE
|
BDBM163924
 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 1 (OX1)
- Orexin receptor type 2
| - US9062078, 176
- US9062078, 55
- US9475819, 55
- US9637496, 55
- US9695183, 55
|
BDBM164108
 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Orexin receptor type 1
- Orexin receptor type 1 (OX1)
- Orexin receptor type 2
| - US9062078, 238
- US9062078, 297
- US9475819, 238
- US9637496, 395
- US9695183, 238
- US9695183, 297
|
BDBM173337
 | 8 | 14 | 0 | 2 | 0 | 0 | 0 | 0 | - Cytochrome P450 3A
- P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10323032, Example 58
- US9096596, 58
- US9604982, Example 58
|
BDBM17662
 | 17 | 2 | 0 | 5 | 0 | 0 | 0 | 0 | - GRIA1
- GRIA2
- GRIA3
- GRIK1
- Glutamate Carboxypeptidase II (GCPII)
- Glutamate receptor 1
- Glutamate receptor ionotropic AMPA
- Glutamate receptor ionotropic, AMPA 2
- Glutamate receptor ionotropic, AMPA 4
- Glutamate receptor ionotropic, kainate
- Glutamate receptor ionotropic, kainate 1
- Glutamate receptor ionotropic, kainate 2
- Grik5
- Ionotropic glutamate receptor kainate 2/5
- Metabotropic glutamate receptor 1
- Metabotropic glutamate receptor 2
- Metabotropic glutamate receptor 4 (mGluR4)
- Metabotropic glutamate receptor 6
- NMDA receptor subunit 2C (GluN2C)
| - (2S)-2-amino-3-(3-hydroxy-5-methyl-1,2-oxazol-4-yl)propanoic acid
- 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid
- AMPA
- CHEMBL276815
|
BDBM17747
 | 3 | 21 | 0 | 0 | 0 | 0 | 0 | 0 | - 6His.FMS.538-922(FGFR)
- Alpha-synuclein
- Beta amyloid A4 protein
- Epidermal growth factor receptor
- Insulin-like growth factor I receptor
- Luciferin 4-monooxygenase
- Macrophage colony-stimulating factor 1 receptor (aa 538-972)
- Platelet-derived growth factor receptor beta
- Proto-oncogene tyrosine-protein kinase receptor Ret
- Receptor tyrosine-protein kinase erbB-2
- Tau
- Vascular endothelial growth factor receptor 1
- cFMS -Tie-2 Chimera
| - (3Z)-3-{[4-(dimethylamino)phenyl]methylidene}-2,3-dihydro-1H-indol-2-one
- CHEMBL328710
- SU 4312
- SU4312
|
BDBM179892
 | 8 | 8 | 0 | 8 | 0 | 0 | 0 | 0 | | - US10287250, Compound C.11
- US10752592, Compound TABLE C.-3
- US9133125, Table C, Compound 10
- US9133125, Table C, Compound 11
- US9656961, Example 00161
|
BDBM198202
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Non-receptor tyrosine-protein kinase TYK2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| - BDBM198340
- US9216999, 10
- US9556187, Example 141
|
BDBM202838
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - B-RAF V600E
- C-RAF
- RAF proto-oncogene serine/threonine-protein kinase
- Serine/threonine-protein kinase B-raf
| - US10245267, Example 650
- US10709712, Example 189
- US9242969, 189
- US9694016, 650
|
BDBM207992
 | 18 | 4 | 2 | 0 | 0 | 0 | 0 | 0 | - Acyl-protein thioesterase 1
- Acyl-protein thioesterase 1 (APT1 I75L)
- Acyl-protein thioesterase 1 (APT1 I75L/S82A)
- Acyl-protein thioesterase 1 (APT1 I75L/S82A/Q83P)
- Acyl-protein thioesterase 1 (APT1 I75L/S82A/Q83P/R149H/A150R/S151A)
- Acyl-protein thioesterase 1 (APT1 L176M)
- Acyl-protein thioesterase 1 (APT1 Q83P)
- Acyl-protein thioesterase 2
- Acyl-protein thioesterase 2 (APT2 H152R)
- Acyl-protein thioesterase 2 (APT2 L78I)
- Acyl-protein thioesterase 2 (APT2 L78I/A85S)
- Acyl-protein thioesterase 2 (APT2 L78I/A85S/P86Q)
- Acyl-protein thioesterase 2 (APT2 L78I/A85S/P86Q/H152R/R153A/A154S)
- Acyl-protein thioesterase 2 (APT2 M178L)
- Acyl-protein thioesterase 2 (APT2 P86Q)
- Acyl-protein thioesterase 2 (APT2 S122A)
- Pyridoxal kinase
| |
BDBM20800
 | 8 | 13 | 1 | 2 | 0 | 0 | 0 | 0 | - Endoplasmin
- Heat Shock Protein 90 (Hsp90)
- Heat shock protein 75 kDa, mitochondrial
- Heat shock protein 90 beta
- Heat shock protein HSP 90-alpha
- Heat shock protein HSP 90-beta
- Histone deacetylase
| - 2-amino-6-halopurine analogue, 20
- 6-chloro-9-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]-9H-purin-2-amine
- CHEMBL467399
- hsp90_107
|
BDBM21123
 | 12 | 6 | 0 | 6 | 0 | 0 | 0 | 0 | - Cannabinoid receptor
- Delta-type opioid receptor
- Mu-type opioid receptor
- Opioid receptors; mu & delta
- mu/kappa opioid receptor
| - (2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]propanamido]acetamido}-3-phenylpropanamide
- Enkephalin Amide
- YDAGF-NH2
|
BDBM230120
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Tyrosine-protein kinase BTK
- Tyrosine-protein kinase JAK2
| - US10106559, Example 73
- US10435415, Example 73
- US9334290, 49
- US9334290, 50
- US9334290, 73
- US9850258, Example 73
|
BDBM23399
 | 4 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 9
- HIV-1 Integrase
- Hepatitis C virus NS5B RNA-dependent RNA polymerase
- Human immunodeficiency virus type 1 integrase
- Integrase
- Reverse transcriptase
| - 4-{1-[(4-fluorophenyl)methyl]-1H-pyrrol-2-yl}-2,4-dioxobutanoic acid
- CHEMBL421353
- CHEMBL50605
- L-731988
|
BDBM235766
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | | |
BDBM237920
 | 0 | 2 | 3 | 19 | 0 | 0 | 0 | 0 | - 5'-AMP-activated protein kinase subunit beta-1
- 5'-AMP-activated protein kinase subunit gamma-1
- 5'-AMP-activated protein kinase Complex 1
- 5'-AMP-activated protein kinase catalytic subunit alpha-1/beta-1/gamma-1
- 5-hydroxytryptamine receptor 2B
- AMPK alpha1/beta2/gamma1
- AMPK alpha2/beta1/gamma1
- AMPK alpha2/beta2/gamma3
- Phosphodiesterase 3
- Prkaa1/Prkab2/Prkag1
| |
BDBM246861
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase Mer
- Tyrosine-protein kinase receptor TYRO3
- Tyrosine-protein kinase receptor UFO
| - 3-[1-(6- chloropyridin-2- yl)pyrrolidin-3-yl]-3- [4-(7H-pyrrolo[2,3- d]pyrimidin-4-yl)- 1H-pyrazol-1- yl]propanenitrile
- US10005788, 2 (2nd peak, cis-)
- US10053465, 3
- US10065963, Compound 3
- US10125150, Example 3
- US10336759, # 3
- US10479803, Example 3
- US10519163, Example 3
- US10675284, Example 3
- US9732097, Example 3
|
BDBM249391
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Fibroblast growth factor receptor
- Fibroblast growth factor receptor 1
- Fibroblast growth factor receptor 2
- Fibroblast growth factor receptor 3
- Fibroblast growth factor receptor 4
- VEGF-receptor 2 and Fibroblast growth factor receptor 1
- VEGF-receptor 2 and Fibroblast growth factor receptor 2
| - US10537571, Compound 100
- US10912774, Compound 100
- US9434697, 100
- US9730931, Compound 100
|
BDBM254258
 | 5 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C8
- Cytochrome P450 2C9
- Cytochrome P450 2D6
- Cytochrome P450 3A
- P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
| - US10112937, Example 148
- US10150765, Example 148
- US10703749, Example 148
- US9464084, 148
|
BDBM255474
 | 22 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | - 5-hydroxytryptamine receptor 1B
- 5-hydroxytryptamine receptor 1D
- 5-hydroxytryptamine receptor 2A
- 5-hydroxytryptamine receptor 2B
- 5-hydroxytryptamine receptor 2C
- 5-hydroxytryptamine receptor 5A
- 5-hydroxytryptamine receptor 6
- 5-hydroxytryptamine receptor 7
- Adrenergic alpha1B
- Alpha-1A adrenergic receptor
- Alpha-2A adrenergic receptor
- Alpha-2B adrenergic receptor
- Alpha-2C adrenergic receptor
- D(1A) dopamine receptor
- D(2) dopamine receptor
- D(3) dopamine receptor
- Gamma-aminobutyric acid receptor subunit alpha-1
- Histamine H1 receptor
| |
BDBM2581
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Beta-chymotrypsin
- Beta-lactamase AmpC
- CDK2/Cyclin E/G1/S-specific cyclin E2
- CaM kinase II
- Cyclin-Dependent Kinase 4 (CDK4)
- Malate dehydrogenase
- Mixed Lineage Kinase 1 (MLK1)
- Mixed Lineage Kinase 3 (MLK3)
- Myosin light chain kinase, smooth muscle
- Protein Kinase C
- Protein kinase C (PKC)
- Protein kinase C alpha type
- Tyrosine-protein kinase JAK3
- Zinc finger protein GLI1
- Zinc finger protein GLI2
- cAMP-Dependent Protein Kinase (PKA)
- cAMP-dependent protein kinase (PKA)
- cAMP-dependent protein kinase catalytic subunit gamma
- cGMP-Dependent Protein Kinase
| - 3,13,23-triazahexacyclo[14.7.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tricosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-12-one
- CHEMBL16958
- K-252c
|
BDBM261946
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Fibroblast growth factor receptor 1
- Fibroblast growth factor receptor 2
- Fibroblast growth factor receptor 3
- Fibroblast growth factor receptor 4
| - 3-(2,6-difluoro-3,5-dimethoxyphenyl)-7-(1,3-dimethyl-1H-pyrazol-4-yl)-1-(1-methyl-1H-pyrazol-4-yl)-3,4-dihydropyrido[4,3-d]pyrimidin-2(1H)-one
- US10251892, Example 100
- US10632126, Example 47
- US9708318, 100
- US9708318, 47
|
BDBM279090
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C
- Calcium/calmodulin-dependent 3',5'-cyclic phosphodiesterase 1A
- Phosphodiesterase, PDE1/PDE5
| - 5-(2-ethoxy-3-pyridyl)-3-methyl-1-[1-methylpropyl]-N-[(1-methyl-1,2,4-triazol-3-yl)methyl]pyrazolo[4,3-b]pyridin-7-amine,enantiomer 1
- US10034861, Example 121
- US10034861, Example 122
- US10512632, Example 122
- US10766893, Example S122
- US10806718, Example 122
|
BDBM279092
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C
- Calcium/calmodulin-dependent 3',5'-cyclic phosphodiesterase 1A
- Phosphodiesterase, PDE1/PDE5
| - 5-(2-ethoxy-3-pyridyl)-3-methyl-N-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1-[1-methylpropyl]pyrazolo[4,3-b]pyridin-7-amine,enantiomer 1
- US10034861, Example 123
- US10034861, Example 124
- US10512632, Example 123
- US10766893, Example S124
- US10806718, Example 124
|
BDBM279105
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C
- Calcium/calmodulin-dependent 3',5'-cyclic phosphodiesterase 1A
- Phosphodiesterase, PDE1/PDE5
| - 5-(2-ethoxy-3-pyridyl)-1-[1-methylpropyl]-N-(1H-pyrazol-3-ylmethyl)pyrazolo[4,3-b]pyridin-7-amine, enantiomer 1
- US10034861, Example 136
- US10034861, Example 137
- US10512632, Example 137
- US10766893, Example S137
- US10806718, Example 137
|
BDBM279107
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C
- Calcium/calmodulin-dependent 3',5'-cyclic phosphodiesterase 1A
- Phosphodiesterase, PDE1/PDE5
| - 5-(2-ethoxy-3-pyridyl)-N-[(5-methyl-1,3,4-oxadiazol-2-yl)methyl]-1-[1-methylpropyl]pyrazolo[4,3-b]pyridin-7-amine,enantiomer 1
- US10034861, Example 138
- US10034861, Example 139
- US10512632, Example 139
- US10766893, Example S139
- US10806718, Example 139
|
BDBM279109
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C
- Calcium/calmodulin-dependent 3',5'-cyclic phosphodiesterase 1A
- Phosphodiesterase, PDE1/PDE5
| - 5-(2-ethoxy-3-pyridyl)-1-[1-methylpropyl]-N-[(1-methyl-1,2,4-triazol-3-yl)methyl]pyrazolo[4,3-b]pyridin-7-amine,enantiomer 1
- US10034861, Example 140
- US10034861, Example 141
- US10512632, Example 141
- US10766893, Example S141
- US10806718, Example 141
|
BDBM280739
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2D6
- Glutamate receptor ionotropic, NMDA 2B
- Melanin-concentrating hormone receptor 2/HERG
- Potassium voltage-gated channel subfamily H member 2
| - US10030026, Compound LX-1
- US10221182, Compound LX-1
- US10294230, Compound LX-1
- US10420768, Compound LX-1
- US10584127, Compound LX-1
- US9968610, Compound LX-1
|
BDBM28393
 | 9 | 15 | 0 | 0 | 0 | 0 | 0 | 0 | - Adenosine deaminase
- Homo sapiens phosphodiesterase 2A (PDE2A)
- Phosphodiesterase 1
- Phosphodiesterase 11A (PDE11A)
- Phosphodiesterase 3
- Phosphodiesterase 8
- Phosphodiesterase 9A
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
- cAMP-specific 3',5'-cyclic phosphodiesterase 4A
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
- cAMP-specific 3',5'-cyclic phosphodiesterase 4C isoform 1
- cAMP-specific 3',5'-cyclic phosphodiesterase 4D
- cGMP-specific 3',5'-cyclic phosphodiesterase
| - (+)-EHNA
- (2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol
- CHEMBL296435
|
BDBM284762
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Homo sapiens phosphodiesterase 2A (PDE2A)
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
| - US10023575, Example 53
- US10023575, Example 54
- US10023575, Example 85a
- US10023575, Example 86a
- US10023575, Example 86b
- US10479794, Example 86b
- US10875867, Example 54
|
BDBM284777
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Homo sapiens phosphodiesterase 2A (PDE2A)
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
| - US10023575, Example 68
- US10023575, Example 69
- US10023575, Example 70
- US10023575, Example 71
- US10479794, Example 71
- US10875867, Example 71
|
BDBM284781
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - 3',5'-cyclic phosphodiesterase
- Homo sapiens phosphodiesterase 2A (PDE2A)
- cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A
| - US10023575, Example 72
- US10023575, Example 73
- US10023575, Example 74
- US10023575, Example 75
- US10479794, Example 75
- US10875867, Example 75
|
BDBM286984
 | 4 | 20 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytoplasmic tyrosine-protein kinase BMX
- Eukaryotic translation initiation factor 2-alpha kinase 3
- Fibroblast growth factor receptor 1
- Fibroblast growth factor receptor 2
- Fibroblast growth factor receptor 3
- Fibroblast growth factor receptor 4
- Macrophage colony stimulating factor receptor
- Serine/threonine-protein kinase TAO2
- Tyrosine-protein kinase Blk
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase Lyn
- Vascular endothelial growth factor receptor 2
- Vascular endothelial growth factor receptor 3
| - 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one
- US10294223, Cpd No. 6
- US9567334, Example 6
- US9815834, Compound 6
|
BDBM291233
 | 0 | 24 | 0 | 0 | 0 | 0 | 0 | 0 | - Fibroblast growth factor receptor 1
- Fibroblast growth factor receptor 2
- Fibroblast growth factor receptor 3
- Fibroblast growth factor receptor 4
| - N-{3-[2'-(2,6-difluoro-3,5-dimethoxyphenyl)-3'-oxo-2',3'-dihydro-1'H-spiro[cyclopropane-1,4'-[2,7]naphthyridin]-6'-yl]phenyl}acrylamide
- US10016438, Example 1
- US9580423, Example 1
- US9801889, Example 1
|
BDBM291234
 | 0 | 24 | 0 | 0 | 0 | 0 |
Search and Browse
